Aveanna Healthcare Holdings Inc. $AVAH Shares Sold by Emerald Advisers LLC

Emerald Advisers LLC lessened its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 3.3% in the 1st quarter, Holdings Channel reports. The fund owned 1,690,457 shares of the company’s stock after selling 58,268 shares during the quarter. Emerald Advisers LLC’s holdings in Aveanna Healthcare were worth $10,887,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the business. Dynamic Technology Lab Private Ltd grew its position in shares of Aveanna Healthcare by 8.9% in the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after purchasing an additional 1,151 shares in the last quarter. Barclays PLC lifted its position in Aveanna Healthcare by 0.8% during the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after buying an additional 1,366 shares in the last quarter. Franklin Resources Inc. boosted its stake in Aveanna Healthcare by 4.5% during the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after buying an additional 1,528 shares during the last quarter. Intech Investment Management LLC boosted its stake in Aveanna Healthcare by 9.8% during the fourth quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock worth $159,000 after buying an additional 1,739 shares during the last quarter. Finally, Balboa Wealth Partners boosted its stake in Aveanna Healthcare by 13.5% during the fourth quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock worth $138,000 after buying an additional 2,007 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on AVAH. Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target for the company in a research note on Friday, March 20th. BMO Capital Markets decreased their target price on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. Truist Financial lifted their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a research report on Wednesday, May 20th. Finally, Royal Bank Of Canada raised shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price target on the stock in a research note on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $10.56.

Insider Transactions at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 7,000,000 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the sale, the insider directly owned 252,899 shares in the company, valued at $1,578,089.76. This represents a 96.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Patrick A. Cunningham sold 125,000 shares of the stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total transaction of $948,750.00. Following the sale, the insider directly owned 212,755 shares in the company, valued at $1,614,810.45. This represents a 37.01% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 31,305,664 shares of company stock valued at $215,555,910. 5.30% of the stock is owned by insiders.

Aveanna Healthcare Trading Down 0.3%

Shares of NASDAQ AVAH opened at $9.67 on Tuesday. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. The stock has a market capitalization of $2.11 billion, a PE ratio of 8.19, a PEG ratio of 0.96 and a beta of 1.89. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.73 and a twelve month high of $10.32. The stock has a fifty day simple moving average of $7.72 and a 200-day simple moving average of $7.59.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The firm had revenue of $647.91 million for the quarter, compared to analyst estimates of $613.22 million. The business’s revenue was up 15.9% on a year-over-year basis. On average, equities analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current year.

Aveanna Healthcare Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.